Rhino Gold
Argentine tablet with a caffeine-led energy profile — nine declared actives.
See details & price →Ginkgo biloba L.
Emerging evidence
A widely sold circulation botanical from one of the oldest tree species on earth — with one safety point, a medication interaction, worth knowing before you take it.
Relevant to: Circulation · Men's Health
Ginkgo leaf extract is one of the most-sold botanicals in the world. The clinically studied preparation is EGb 761, standardised to 24% flavone glycosides and 6% terpene lactones (ginkgolides and bilobalide) — a specification worth looking for, because unstandardised ginkgo leaf varies widely.
Standardisation also matters for safety: ginkgolic acids, present in raw leaf, are allergenic and cytotoxic, and quality extracts limit them to under 5 parts per million.
Cognition and dementia. The Ginkgo Evaluation of Memory (GEM) study — over 3,000 older adults followed for a median of six years, published in JAMA in 2008 — found 120 mg twice daily did not reduce the incidence of dementia or Alzheimer's disease. That is the largest and most rigorous test the ingredient has faced.
Peripheral circulation. A Cochrane review of ginkgo for intermittent claudication found a small increase in pain-free walking distance.
Tinnitus and vertigo. Mixed results across small trials.
Ginkgolides inhibit platelet-activating factor, which affects platelet aggregation. There are published case reports of bleeding events — including intracranial haemorrhage — in people combining ginkgo with anticoagulant or antiplatelet medication.
The practical rules: do not combine ginkgo with warfarin, direct oral anticoagulants, aspirin or clopidogrel without medical advice; stop it at least two weeks before scheduled surgery; and avoid it entirely if you have a bleeding disorder. It may also lower the seizure threshold, which is relevant for anyone with epilepsy.
Products on this site with Ginkgo Biloba on the label. The amount per serving is printed by each manufacturer on the pack.
Argentine tablet with a caffeine-led energy profile — nine declared actives.
See details & price →A seven-ingredient Turkish herbal capsule led by L-arginine and epimedium, with ginseng, maca and çakşır root.
See details & price →The largest trial to test it — GEM, over 3,000 older adults followed for a median six years, published in JAMA in 2008 — found no reduction in dementia or Alzheimer's incidence. Smaller studies are mixed.
Not without medical advice. Ginkgolides affect platelet aggregation and there are published case reports of serious bleeding when ginkgo is combined with anticoagulant or antiplatelet drugs. It should also be stopped two weeks before surgery.
The standardised extract used in most clinical research: 24% flavone glycosides, 6% terpene lactones, with ginkgolic acids limited to under 5 ppm. Unstandardised ginkgo leaf varies widely and can carry higher levels of those allergenic acids.
On a general "improves circulation" rationale.